WATSON 453 (Guanfacine 2 mg)

Pill imprint WATSON 453 has been identified as Guanfacine hydrochloride 2 mg.

Guanfacine is used in the treatment of adhd; tourette's syndrome; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. There is no proven risk in humans during pregnancy. Guanfacine 2 mg is not a controlled substance under the Controlled Substance Act (CSA).

Guanfacine hydrochloride

Imprint:

WATSON 453

Strength:

2 mg

Color:

Orange

Size:

8.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Antiadrenergic agents, centrally acting

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Pharmaceuticals

National Drug Code (NDC):

00591-0453

Inactive Ingredients:

lactose anhydrous
D&C Yellow No. 10
FD&C Red No. 40
povidone k29/32
stearic acid
microcrystalline cellulose
aluminum oxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.